Reply

Comment

Marco Coassin et al. J Cataract Refract Surg. 2016 Dec.

. 2016 Dec;42(12):1852-1853.

doi: 10.1016/j.jcrs.2016.11.030.

No abstract available

Comment on

Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
Coassin M, Iovieno A, Soldani A, Cavuto S, Cimino L, Sartori A, Formisano D, Fontana L. Coassin M, et al. J Cataract Refract Surg. 2016 Aug;42(8):1119-25. doi: 10.1016/j.jcrs.2016.04.031. J Cataract Refract Surg. 2016. PMID: 27531286 Clinical Trial.
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
Levitz L. Levitz L. J Cataract Refract Surg. 2016 Dec;42(12):1852. doi: 10.1016/j.jcrs.2016.10.018. J Cataract Refract Surg. 2016. PMID: 28007131 No abstract available.